YOANA SILVA JIMENEZ: Open Payments
NPI 1700521168 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $249 |
| Gilead Sciences, Inc. | 1 | $144 |
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| Novo Nordisk Inc | 1 | $120 |
| Corcept Therapeutics | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Lilly USA, LLC | 1 | $26 |
| Amgen Inc. | 1 | $18 |
Products named: Bimzelx, GVOKE HYPOPEN, Opzelura, Wegovy, Korlym, SHINGRIX, ZEPBOUND, REPATHA.
Industry payments across CA — which companies pay providers there.
